Added value of molecular biological analysis in diagnosis and clinical management of liposarcoma: A 30-year single-institution experience

Annals of Surgical Oncology

Volumn 17, Issue 3, 2010, Pages 686-693

  De Vreeze, Ronald S A ^a   De Jong, Daphne ^a   Nederlof, Petra M ^a   Ariaens, Aafke ^a   Tielen, Ivon H G ^a   Frenken, Luc ^a   Haas, Rick L ^a   Van Coevorden, Frits ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER THERAPY; CELL DIFFERENTIATION; CLASSIFICATION; CLINICAL ASSESSMENT; CYTOGENETICS; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HOSPITAL; HUMAN; LIPOSARCOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL INFORMATION; MOLECULAR BIOLOGY; MYXOSARCOMA; PATIENT REFERRAL;

CHROMOSOMES, HUMAN, PAIR 12; COHORT STUDIES; CYCLIN-DEPENDENT KINASE 4; DIAGNOSIS, DIFFERENTIAL; DNA, NEOPLASM; FEMALE; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; LIPOSARCOMA; MALE; ONCOGENE PROTEINS, FUSION; POLYMERASE CHAIN REACTION; PROGNOSIS; SURVIVAL RATE;

EID: 77149149403     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0806-9     Document Type: Article

References (34)

1. LG Kindblom 2006 Lipomatous tumors-how we have reached our present views, what controversies remain and why we still face diagnostic problems: a tribute to Dr Franz Enzinger Adv Anat Pathol. 13 279 285 10.1097/01.pap.0000213053. 00060.5a 17075293 (Pubitemid 44673443)
2. RS de Vreeze D de Jong IH Tielen, et al. 2009 Primary retroperitoneal myxoid/round cell liposarcoma is a nonexisting disease: an immunohistochemical and molecular biological analysis Mod Pathol. 22 2 223 31 10.1038/modpathol. 2008.164 18820664
3. RS de Vreeze D de Jong RL Haas 2008 Effectiveness of radiotherapy in myxoid sarcomas is associated with a dense vascular pattern Int J Radiat Oncol Biol Phys 72 5 1480 7 18448271
4. G Pitson P Robinson D Wilke, et al. 2004 Radiation response: an additional unique signature of myxoid liposarcoma Int J Radiat Oncol Biol Phys. 60 522 526 15380587
5. K Engstrom P Bergh CG Cederlund, et al. 2007 Irradiation of myxoid/round cell liposarcoma induces volume reduction and lipoma-like morphology Acta Oncol. 46 838 845 10.1080/02841860601080415 17653909 (Pubitemid 47123772)
6. RL Jones C Fisher O Al-Muderis, et al. 2005 Differential sensitivity of liposarcoma subtypes to chemotherapy Eur J Cancer. 41 2853 2860 10.1016/j.ejca.2005.07.023 1:CAS:528:DC%2BD2MXht1OntLzP 16289617 (Pubitemid 41713123)
7. F Grosso RL Jones GD Demetri, et al. 2007 Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study Lancet Oncol. 8 595 602 10.1016/S1470-2045(07)70175-4 1:CAS:528: DC%2BD2sXnsFKkur0%3D 17586092 (Pubitemid 46995623)
8. AP Dei Tos C Doglioni S Piccinin, et al. 2000 Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours J Pathol. 190 531 536 10.1002/(SICI)1096-9896(200004)190:5<531::AID- PATH579>3.0.CO;2-W 1:CAS:528:DC%2BD3cXivVSrt7g%3D 10727978
9. I Hostein M Pelmus A Aurias, et al. 2004 Evaluation of MDM2 and CDK4 amplification by real-time PCR on paraffin wax-embedded material: a potential tool for the diagnosis of atypical lipomatous tumours/well-differentiated liposarcomas J Pathol. 202 95 102 10.1002/path.1495 1:CAS:528: DC%2BD2cXnslCntA%3D%3D 14694526 (Pubitemid 38072850)
10. I Panagopoulos F Mertens M Isaksson, et al. 2000 A novel FUS/CHOP chimera in myxoid liposarcoma Biochem Biophys Res Commun. 279 838 845 10.1006/bbrc.2000.4026 1:CAS:528:DC%2BD3MXivVanuw%3D%3D 11162437 (Pubitemid 32042864)
11. I Panagopoulos M Hoglund F Mertens, et al. 1996 Fusion of the EWS and CHOP genes in myxoid liposarcoma Oncogene. 12 489 494 1:CAS:528: DyaK28XhtFCms7w%3D 8637704
12. T Hosaka Y Nakashima K Kusuzaki, et al. 2002 A novel type of EWS-CHOP fusion gene in two cases of myxoid liposarcoma J Mol Diagn. 4 164 171 1:CAS:528:DC%2BD38XmvVSqtbY%3D 12169678
13. S Singer ND Socci G Ambrosini, et al. 2007 Gene expression profiling of liposarcoma identifies distinct biological types/subtypes and potential therapeutic targets in well-differentiated and dedifferentiated liposarcoma Cancer Res. 67 6626 6636 10.1158/0008-5472.CAN-07-0584 1:CAS:528: DC%2BD2sXnslOjtLw%3D 17638873
14. A Italiano N Cardot F Dupre, et al. 2007 Gains and complex rearrangements of the 12q13-15 chromosomal region in ordinary lipomas: the "missing link" between lipomas and liposarcomas? Int J Cancer. 121 308 315 10.1002/ijc.22685 1:CAS:528:DC%2BD2sXmslOlt74%3D 17372913 (Pubitemid 46917699)
15. JP Schouten CJ McElgunn R Waaijer, et al. 2002 Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification Nucleic Acids Res. 30 e57 10.1093/nar/gnf056 12060695
16. K Thway C Fisher 2009 Histopathological diagnostic discrepancies in soft tissue tumours referred to a specialist centre Sarcoma. 2009 741975 10.1155/2009/741975 19503800
17. CA Presant WO Russell RW Alexander, et al. 1986 Soft-tissue and bone sarcoma histopathology peer review: the frequency of disagreement in diagnosis and the need for second pathology opinions. The Southeastern Cancer Study Group experience J Clin Oncol. 4 1658 1661 1:STN:280:DyaL2s%2FjsFOmsA%3D%3D 3772418
18. TA Alvegard NO Berg 1989 Histopathology peer review of high-grade soft tissue sarcoma: the Scandinavian Sarcoma Group experience J Clin Oncol. 7 1845 1851 1:STN:280:DyaK3c%2FmtlKlsA%3D%3D 2685180
19. D Massi G Beltrami R Capanna, et al. 2004 Histopathological re-classification of extremity pleomorphic soft tissue sarcoma has clinical relevance Eur J Surg Oncol. 30 1131 1136 10.1016/j.ejso.2004.07.018 1:STN:280:DC%2BD2crltVOlug%3D%3D 15522563 (Pubitemid 40267821)
20. KA Downes JR Goldblum EA Montgomery, et al. 2001 Pleomorphic liposarcoma: a clinicopathologic analysis of 19 cases Mod Pathol. 14 179 184 10.1038/modpathol.3880280 1:STN:280:DC%2BD3M7ntVWhtw%3D%3D 11266523 (Pubitemid 32246821)
21. AF Nascimento CP Raut 2008 Diagnosis and management of pleomorphic sarcomas (so-called "MFH") in adults J Surg Oncol. 97 330 339 10.1002/jso.20972 18286476 (Pubitemid 351358581)
22. JL Hornick MW Bosenberg T Mentzel, et al. 2004 Pleomorphic liposarcoma: clinicopathologic analysis of 57 cases Am J Surg Pathol. 28 1257 1267 10.1097/01.pas.0000135524.73447.4a 15371941 (Pubitemid 39336365)
23. B Fritz F Schubert G Wrobel, et al. 2002 Microarray-based copy number and expression profiling in dedifferentiated and pleomorphic liposarcoma Cancer Res. 62 2993 2998 1:CAS:528:DC%2BD38XksVyrurk%3D 12036902
24. S Gebhard JM Coindre JJ Michels, et al. 2002 Pleomorphic liposarcoma: clinicopathologic, immunohistochemical, and follow-up analysis of 63 cases: a study from the French Federation of Cancer Centers Sarcoma Group Am J Surg Pathol. 26 601 616 10.1097/00000478-200205000-00006 11979090 (Pubitemid 34438720)
25. A Idbaih JM Coindre J Derre, et al. 2005 Myxoid malignant fibrous histiocytoma and pleomorphic liposarcoma share very similar genomic imbalances Lab Invest. 85 176 181 10.1038/labinvest.3700202 1:CAS:528:DC%2BD2MXhtFWgtrs%3D 15702084 (Pubitemid 40208921)
26. S Pilotti TG Della C Lavarino, et al. 1997 Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms J Pathol. 181 14 24 10.1002/(SICI)1096-9896(199701)181:1<14::AID- PATH730>3.0.CO;2-O 1:STN:280:DyaK2s3isFKmtA%3D%3D 9071998 (Pubitemid 27099769)
27. JM Berner A Forus A Elkahloun, et al. 1996 Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas Genes Chromosomes Cancer. 17 254 259 10.1002/(SICI)1098-2264(199612)17:4<254::AID-GCC7>3.0.CO;2-2 1:CAS:528:DyaK2sXotlSq 8946207 (Pubitemid 26424003)
28. N Sirvent JM Coindre G Maire, et al. 2007 Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR Am J Surg Pathol. 31 1476 1489 10.1097/PAS.0b013e3180581fff 17895748 (Pubitemid 47482460)
29. AP Dei Tos C Doglioni S Piccinin, et al. 1997 Molecular abnormalities of the p53 pathway in dedifferentiated liposarcoma J Pathol. 181 8 13 10.1002/(SICI)1096-9896(199701)181:1<8::AID-PATH700>3.0.CO;2-# 1:STN:280:DyaK2s3isFKmtw%3D%3D 9071997 (Pubitemid 27099768)
30. HJ Mankin CJ Mankin MA Simon 1996 The hazards of the biopsy, revisited. Members of the Musculoskeletal Tumor Society J Bone Joint Surg Am. 78 656 663 1:STN:280:DyaK283hvFSisQ%3D%3D 8642021
31. I Ray-Coquard P Thiesse D Ranchere-Vince, et al. 2004 Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomas Ann Oncol. 15 307 315 10.1093/annonc/mdh058 1:STN:280:DC%2BD2c%2FlvValsA%3D%3D 14760127 (Pubitemid 38262633)
32. A Rydholm 1997 Centralization of soft tissue sarcoma. The southern Sweden experience Acta Orthop Scand Suppl. 273 4 8 1:STN:280:DyaK2s3htVGjtQ%3D%3D 9057580
33. R Clasby K Tilling MA Smith, et al. 1997 Variable management of soft tissue sarcoma: regional audit with implications for specialist care Br J Surg. 84 1692 1696 10.1002/bjs.1800841213 1:STN:280:DyaK1c7htVSltQ%3D%3D 9448617
34. T van Dalen HJ Hoekstra AN van Geel, et al. 2001 Locoregional recurrence of retroperitoneal soft tissue sarcoma: second chance of cure for selected patients Eur J Surg Oncol. 27 564 568 10.1053/ejso.2001.1166 11520090 (Pubitemid 32842728)